Literature DB >> 8899837

Oxidation of human insulin-like growth factor I in formulation studies, II. Effects of oxygen, visible light, and phosphate on methionine oxidation in aqueous solution and evaluation of possible mechanisms.

J Fransson1, A Hagman.   

Abstract

PURPOSE: The oxidation of methionine in human Insulin-like Growth Factor I (hIGF-I) in aqueous solution was studied with respect to oxygen, visible light and sodium phosphate.
METHODS: Aqueous solutions of hIGF-I were prepared with different amounts of phosphate and dissolved oxygen. The solutions were stored either in darkness or exposed to artificial visible light. The oxidized hIGF-I was quantified by RP-HPLC. A two level full factorial experimental design, with two levels of each of the three factors studied, was used.
RESULTS: Oxidation was found to be positively correlated with light oxygen content and, interestingly, phosphate. The increasing effect of phosphate on the oxidation appears not to originate from metal contaminants. The influence of both oxygen and phosphate increased with time. The pH dependence of oxidation indicated the formation of a phosphorylated sulfonium ion as an oxidation intermediate. A significant interaction effect between phosphate and visible light suggested participation of radicals.
CONCLUSIONS: Factorial experiments provide a valuable tool when studying complex mechanisms with interacting factors. The oxidation of methionine in hIGF-I is significantly affected by light but also by the presence of phosphate buffer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899837     DOI: 10.1023/a:1016015226211

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Chemometrics in pharmaceutical analysis.

Authors:  D L Massart; L Buydens
Journal:  J Pharm Biomed Anal       Date:  1988       Impact factor: 3.935

2.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization.

Authors:  S Li; C Schöneich; R T Borchardt
Journal:  Biotechnol Bioeng       Date:  1995-12-05       Impact factor: 4.530

3.  An experimental model for kinetic preformulation studies on oxidation sensitive substances.

Authors:  P Fyhr; A Brodin
Journal:  Acta Pharm Suec       Date:  1987

4.  Metal-catalysed oxidation and post-Amadori reactions of serum albumin and other model proteins.

Authors:  N Ahmed; J Liggins; A J Furth
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

5.  Isolation and characterization of a glycosylated form of human insulin-like growth factor I produced in Saccharomyces cerevisiae.

Authors:  P Gellerfors; K Axelsson; A Helander; S Johansson; L Kenne; S Lindqvist; B Pavlu; A Skottner; L Fryklund
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

  5 in total
  2 in total

1.  Aggregation of recombinant human interferon alpha 2b in solution: technical note.

Authors:  Llamil Ruiz; Kethia Aroche; Nuria Reyes
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

Review 2.  Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Authors:  Annette Bak; Dennis Leung; Stephanie E Barrett; Seth Forster; Ellen C Minnihan; Andrew W Leithead; James Cunningham; Nathalie Toussaint; Louis S Crocker
Journal:  AAPS J       Date:  2014-11-15       Impact factor: 4.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.